Cargando…

Angiogenesis: Future of pharmacological modulation

Angiogenesis is a fundamental biological process that is regulated by a fine balance between pro- and antiangiogenic molecules, and is deranged in various diseases. Historically, angiogenesis was only implicated in few diseases, such as, cancer, arthritis, and psoriasis. However, in recent years, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisht, Manisha, Dhasmana, D.C., Bist, S.S.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885631/
https://www.ncbi.nlm.nih.gov/pubmed/20606828
http://dx.doi.org/10.4103/0253-7613.62395
_version_ 1782182403907780608
author Bisht, Manisha
Dhasmana, D.C.
Bist, S.S.
author_facet Bisht, Manisha
Dhasmana, D.C.
Bist, S.S.
author_sort Bisht, Manisha
collection PubMed
description Angiogenesis is a fundamental biological process that is regulated by a fine balance between pro- and antiangiogenic molecules, and is deranged in various diseases. Historically, angiogenesis was only implicated in few diseases, such as, cancer, arthritis, and psoriasis. However, in recent years, it has been increasingly evident that excessive, insufficient or abnormal angiogenesis contributes to the pathogenesis of many more disorders. Research in angiogenesis offers a potential to cure a variety of diseases such as Alzheimer's and AIDS. Modulation of angiogenesis may have an impact on diseases in the twenty-first century similar to that which the discovery of antibiotics had in the twentieth century.
format Text
id pubmed-2885631
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28856312010-07-02 Angiogenesis: Future of pharmacological modulation Bisht, Manisha Dhasmana, D.C. Bist, S.S. Indian J Pharmacol Educational Forum Angiogenesis is a fundamental biological process that is regulated by a fine balance between pro- and antiangiogenic molecules, and is deranged in various diseases. Historically, angiogenesis was only implicated in few diseases, such as, cancer, arthritis, and psoriasis. However, in recent years, it has been increasingly evident that excessive, insufficient or abnormal angiogenesis contributes to the pathogenesis of many more disorders. Research in angiogenesis offers a potential to cure a variety of diseases such as Alzheimer's and AIDS. Modulation of angiogenesis may have an impact on diseases in the twenty-first century similar to that which the discovery of antibiotics had in the twentieth century. Medknow Publications 2010-02 /pmc/articles/PMC2885631/ /pubmed/20606828 http://dx.doi.org/10.4103/0253-7613.62395 Text en © Indian Journal of Pharmacology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Educational Forum
Bisht, Manisha
Dhasmana, D.C.
Bist, S.S.
Angiogenesis: Future of pharmacological modulation
title Angiogenesis: Future of pharmacological modulation
title_full Angiogenesis: Future of pharmacological modulation
title_fullStr Angiogenesis: Future of pharmacological modulation
title_full_unstemmed Angiogenesis: Future of pharmacological modulation
title_short Angiogenesis: Future of pharmacological modulation
title_sort angiogenesis: future of pharmacological modulation
topic Educational Forum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885631/
https://www.ncbi.nlm.nih.gov/pubmed/20606828
http://dx.doi.org/10.4103/0253-7613.62395
work_keys_str_mv AT bishtmanisha angiogenesisfutureofpharmacologicalmodulation
AT dhasmanadc angiogenesisfutureofpharmacologicalmodulation
AT bistss angiogenesisfutureofpharmacologicalmodulation